Company / R&D Expense
uniQure N.V. R&D Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$143.8M
FY2024
5-year range
$122.4M / $214.9M
FY2020-FY2024
Trend
-33.1%
vs FY2023
Sector context
#107 of 210
Health Care
What the data says
At $144M, uniQure N.V.'s r&d expense ranks #107 of 210 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $59M in FY2015 to $215M in FY2023.
Based on SEC 10-K filings.
$144M in FY2024 with a 5-year CAGR of +8.7%.
Declined from $198M to $144M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- +8.7%
- 10-Year CAGR
- -
Sector benchmark
#107 of 210 in Health CareTop 51% of 210This company $143.8M Sector average $644.1M
▼
-77.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.7%, indicating consistent growth.
- In FY2024, r&d expense decreased 33.1% year-over-year.
- Ranks #107 out of 210 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $143.8M | -33.1% |
| FY2023 | $214.9M | +8.7% |
| FY2022 | $197.6M | +37.6% |
| FY2021 | $143.5M | +17.3% |
| FY2020 | $122.4M | +29.2% |
| FY2019 | $94.7M | +26.6% |
| FY2018 | $74.8M | +3.7% |
| FY2017 | $72.2M | -0.5% |
| FY2016 | $72.5M | +22.6% |
| FY2015 | $59.1M | +35.1% |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026